Tenofovir alafenamide RIF 718

Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for reduced levels of TAF
Drug 1 effect

Dosed once: AUC decreased 55%; dosed twice: AUC decreased 14%

Drug 2
Drug 2 effect

Not studied

Clinical Effects

Potential decrease in antiretroviral efficacy

Management

Contraindicated. Use alternative agents.

Import ID
718